INR 645.3
(-2.26%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 30.93 Billion INR | 6.57% |
2022 | 29.02 Billion INR | 0.93% |
2021 | 28.75 Billion INR | 9.24% |
2020 | 26.32 Billion INR | 32.33% |
2019 | 19.89 Billion INR | 23.55% |
2018 | 16.1 Billion INR | 7.4% |
2017 | 14.99 Billion INR | 1.83% |
2016 | 14.72 Billion INR | 43.52% |
2015 | 10.25 Billion INR | 25.87% |
2014 | 8.14 Billion INR | 20.23% |
2013 | 6.77 Billion INR | 22.92% |
2012 | 5.51 Billion INR | 27.32% |
2011 | 4.33 Billion INR | 28.05% |
2010 | 3.38 Billion INR | 36.46% |
2009 | 2.47 Billion INR | 12.25% |
2008 | 2.2 Billion INR | 22.33% |
2007 | 1.8 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 Q2 | 30.04 Billion INR | 0.0% |
2023 FY | 30.93 Billion INR | 6.57% |
2023 Q4 | 30.93 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q2 | 29.82 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q4 | 29.02 Billion INR | 0.0% |
2022 FY | 29.02 Billion INR | 0.93% |
2022 Q3 | - INR | -100.0% |
2021 Q2 | 26.98 Billion INR | 0.0% |
2021 Q4 | 28.75 Billion INR | 0.0% |
2021 FY | 28.75 Billion INR | 9.24% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 26.32 Billion INR | 32.33% |
2020 Q4 | 26.32 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 24.86 Billion INR | 0.0% |
2019 Q2 | 17.9 Billion INR | 0.0% |
2019 FY | 19.89 Billion INR | 23.55% |
2019 Q1 | - INR | -100.0% |
2019 Q4 | 19.89 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 16.1 Billion INR | 7.4% |
2018 Q4 | 16.1 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 15.1 Billion INR | 0.0% |
2017 FY | 14.99 Billion INR | 1.83% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 14.65 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q4 | 14.99 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 14.72 Billion INR | 43.52% |
2016 Q4 | 14.72 Billion INR | 0.0% |
2016 Q2 | 10.59 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 FY | 10.25 Billion INR | 25.87% |
2015 Q4 | 10.25 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 10.06 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 8.42 Billion INR | 0.0% |
2014 Q4 | 8.14 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 8.14 Billion INR | 20.23% |
2013 Q2 | 6.11 Billion INR | 0.0% |
2013 FY | 6.77 Billion INR | 22.92% |
2013 Q4 | 6.77 Billion INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q1 | - INR | -100.0% |
2012 Q2 | 5 Billion INR | 0.0% |
2012 FY | 5.51 Billion INR | 27.32% |
2012 Q4 | 5.51 Billion INR | 0.0% |
2011 FY | 4.33 Billion INR | 28.05% |
2011 Q4 | 4.33 Billion INR | 0.0% |
2010 FY | 3.38 Billion INR | 36.46% |
2009 FY | 2.47 Billion INR | 12.25% |
2008 FY | 2.2 Billion INR | 22.33% |
2007 FY | 1.8 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Bal Pharma Limited | 3.2 Billion INR | -865.453% |
Achyut Healthcare Limited | 309.52 Million INR | -9893.488% |
Alkem Laboratories Limited | 155.74 Billion INR | 80.14% |
Divi's Laboratories Limited | 154.7 Billion INR | 80.005% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 78.458% |
Glenmark Life Sciences Limited | 28.5 Billion INR | -8.518% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1636.051% |
Mankind Pharma Limited | 119.63 Billion INR | 74.144% |
Medicamen Biotech Limited | 2.94 Billion INR | -950.244% |
Medico Remedies Limited | 961.95 Million INR | -3115.546% |
Megasoft Limited | 3.65 Billion INR | -745.37% |
Procter & Gamble Health Limited | 7.94 Billion INR | -289.396% |
Piramal Pharma Limited | 153.11 Billion INR | 79.799% |
Sequent Scientific Limited | 15.4 Billion INR | -100.807% |
Sigachi Industries Limited | 6.94 Billion INR | -345.606% |
Ajanta Pharma Limited | 46.38 Billion INR | 33.313% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 96.381% |
Brooks Laboratories Limited | 904.45 Million INR | -3319.969% |
Aarti Pharmalabs Limited | 25.82 Billion INR | -19.794% |
Themis Medicare Limited | 5.66 Billion INR | -446.101% |
Unichem Laboratories Limited | 31.69 Billion INR | 2.402% |
Hester Biosciences Limited | 6.62 Billion INR | -367.007% |
Venus Remedies Limited | 6.26 Billion INR | -393.468% |
Indoco Remedies Limited | 21.44 Billion INR | -44.223% |
Ind-Swift Limited | 6.54 Billion INR | -372.626% |
Aarti Drugs Limited | 24.32 Billion INR | -27.169% |
Alpa Laboratories Limited | 1.82 Billion INR | -1593.777% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | -186.932% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 92.018% |
Granules India Limited | 55.2 Billion INR | 43.974% |
Gufic Biosciences Limited | 10.92 Billion INR | -183.12% |
Hikal Limited | 24.87 Billion INR | -24.368% |
RPG Life Sciences Limited | 5.12 Billion INR | -503.117% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | -37.227% |
Windlas Biotech Limited | 6.26 Billion INR | -393.96% |
ZIM Laboratories Limited | 4.46 Billion INR | -592.267% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | -165.487% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -37.819% |
Jubilant Pharmova Limited | 115.48 Billion INR | 73.216% |
Aurobindo Pharma Limited | 450.71 Billion INR | 93.137% |
Bajaj HealthCare Limited | 7.65 Billion INR | -304.273% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -6469.726% |
Ipca Laboratories Limited | 111.01 Billion INR | 72.137% |
Lasa Supergenerics Limited | 1.5 Billion INR | -1950.263% |
Laurus Labs Limited | 83.87 Billion INR | 63.119% |
NATCO Pharma Limited | 69.06 Billion INR | 55.212% |
Nectar Lifesciences Limited | 21.91 Billion INR | -41.174% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | -31.572% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 79.462% |
Wanbury Limited | 3.43 Billion INR | -800.514% |
Wockhardt Limited | 76.49 Billion INR | 59.561% |
Strides Pharma Science Limited | 58.39 Billion INR | 47.032% |
Bliss GVS Pharma Limited | 12.13 Billion INR | -154.822% |
Suven Life Sciences Limited | 2.84 Billion INR | -985.706% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -743.132% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 52.01% |
Eris Lifesciences Limited | 70.48 Billion INR | 56.118% |
Lupin Limited | 239.97 Billion INR | 87.11% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -500.576% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -664.389% |
Valiant Laboratories Limited | 3.42 Billion INR | -802.632% |
Zydus Lifesciences Limited | 292.8 Billion INR | 89.436% |
FDC Limited | 24.68 Billion INR | -25.328% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 22.556% |
Novartis India Limited | 9.24 Billion INR | -234.426% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1324.928% |
Neuland Laboratories Limited | 18.32 Billion INR | -68.791% |
Morepen Laboratories Limited | 12.93 Billion INR | -139.189% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -1188.504% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -827.708% |